TrialInvestigational new drugs2008

A phase II study of ispinesib (SB-715992) in patients with metastatic or recurrent malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group trial.

Christopher W Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.